Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
May 21, 2024 04:00 ET
|
Medigene AG
Planegg/Martinsried, May 21, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of differentiated T...
Photocat A/S and Nexler Sp. z.o.o. signing a groundbreaking 5-years partnership agreement and NOxOFF license agreement to revolutionize NOx reduction in the roofing industry.
May 21, 2024 03:20 ET
|
Photocat A/S
May 21st 2024 Photocat A/S and Nexler Sp. z.o.o. signing a groundbreaking 5-years partnership agreement and NOxOFF license agreement to revolutionize NOx reduction in the roofing industry. ...
Sydbank A/S køber Coop Bank A/S
May 21, 2024 02:15 ET
|
Sydbank A/S
Selskabsmeddelelse nr. 18/2024Peberlyk 4DK-6200 AabenraaTelefon +45 74 37 37 37Sydbank A/SCVR-nr. DK 12626509, Aabenraasydbank.dk21. maj 2024 Sydbank A/S køber Coop Bank A/S Sydbank A/S og Coop...
Sydbank to acquire Coop Bank A/S
May 21, 2024 02:15 ET
|
Sydbank A/S
Company Announcement No 18/2024Peberlyk 46200 AabenraaDenmarkTel +45 74 37 37 37Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk21 May 2024 Dear Sirs Sydbank to acquire Coop Bank A/S Sydbank...
PGS Introduces New Seismic Data Interpretation Services
May 21, 2024 02:00 ET
|
PGS ASA
May 21, 2024 PGS advances seismic data interpretation capability through a collaboration agreement with Onward, an Austin-based energy innovation platform. PGS is pleased to announce a...
Litchfield Hills Research reiterates buy recommendation at $10.00 per share
May 21, 2024 01:10 ET
|
VIRTUALWARE 2007 SA
New York and Bilbao, Spain, 21 May - US equity research firm Litchfield Hills Research has just published a new analysis of Virtualware (ENXTPA: MLVIR), reiterating its Buy...
Start of Day Message
May 21, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 21 May. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Idorsia announces changes to Idorsia Executive Committee and Board of Directors
May 21, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board – taking...
Idorsia announces changes to Idorsia Executive Committee and Board of Directors
May 21, 2024 01:00 ET
|
Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board – taking...
FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
May 21, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the...